Topical finasteride applies the drug directly to the scalp with the goal of reducing DHT in scalp tissue while minimizing the systemic hormone changes associated with oral finasteride. In theory, a topical formulation could achieve equivalent hair loss efficacy with lower systemic DHT suppression and thus a reduced side effect profile. The early clinical data is promising, though the evidence base is smaller than for the oral form.

Topical finasteride is not FDA-approved in the United States. It is prescribed off-label, typically from compounding pharmacies, and is available through some telehealth hair loss platforms.

The Rationale for Topical Delivery

Oral finasteride 1 mg daily reduces serum DHT by approximately 60-70%. This systemic DHT reduction is what produces side effects in a minority of users, the drug acts throughout the body, not only in the scalp. If a topical formulation could achieve meaningful scalp DHT reduction while keeping serum DHT closer to baseline, it would maintain efficacy while reducing systemic hormonal disruption.

The pharmacokinetic question is whether topical application achieves adequate scalp penetration and whether significant systemic absorption occurs despite the topical route.

What the Clinical Trials Show

The largest published trial of topical finasteride is an Italian randomized controlled study published in the Journal of the European Academy of Dermatology and Venereology (Caserini et al., 2014), followed by a phase III trial (Piraccini et al., 2022).

The phase III trial enrolled 323 men with androgenetic alopecia (Norwood 2-4) and randomized them to topical finasteride 0.25% solution once daily, topical vehicle (placebo), or oral finasteride 1 mg daily, for 24 weeks.

Key findings:

  • Topical finasteride 0.25%: Hair count increased by approximately 13 hairs per cm² versus baseline
  • Oral finasteride 1 mg: Hair count increased by approximately 11 hairs per cm² versus baseline
  • Placebo: Hair count decreased slightly versus baseline
  • Serum DHT reduction: Oral finasteride reduced serum DHT by 62%; topical finasteride reduced serum DHT by 8%

Topical finasteride was non-inferior to oral finasteride for hair count improvement, while producing dramatically less systemic DHT suppression. If the association between side effects and systemic DHT reduction is causal (rather than placebo-mediated), topical finasteride should produce fewer sexual side effects.

Systemic Absorption Data

The 8% serum DHT reduction from topical finasteride versus 62% for oral finasteride in the Piraccini trial represents a meaningful pharmacokinetic difference. Some systemic absorption does occur, topical application is not completely isolated to the scalp, but the proportion reaching systemic circulation is a fraction of the oral route.

Whether 8% systemic DHT reduction is enough to produce sexual side effects in susceptible individuals is not definitively answered by existing trial data. The trial was not powered to detect differences in side effect rates between topical and oral forms, and the 24-week duration was insufficient to capture longer-term side effect patterns.

Formulation Considerations

Topical finasteride is available in concentrations ranging from 0.1% to 0.25% in various delivery vehicles. Common formulations include:

Solution: Applied with a dropper directly to the scalp. Requires drying before contact with others.

Finasteride + minoxidil combination: Several formulations combine topical finasteride with minoxidil, allowing both medications to be applied in a single step. Combination products reduce dosing burden and may improve adherence. Separate studies on combination formulations generally show additive effects on hair count.

Nanoencapsulated finasteride: Some formulations use nanoparticle delivery to enhance scalp penetration while further reducing systemic absorption. This technology is in earlier-stage development and lacks the same trial data as standard topical formulations.

Practical Considerations

Topical finasteride is typically applied once daily. The scalp should be clean and dry before application. Most formulations require 4-6 hours before washing the hair to allow adequate absorption.

Women of childbearing potential should not handle topical finasteride, as the drug can be absorbed through the skin and is teratogenic to developing male fetuses. This same precaution applies to the oral form.

The cost of topical finasteride from compounding pharmacies generally runs higher than oral generic finasteride (which is extremely inexpensive) but comparable to branded topical hair loss treatments.

For the evidence on oral finasteride including side effect rates from the PLESS trial, see Finasteride Side Effects: What the Research Actually Shows. For the minoxidil component of hair loss treatment, see How Long Does Minoxidil Take to Work?